Invention Application
- Patent Title: NOVEL EXOSOME-BASED ANTICANCER AGENT
-
Application No.: US17712155Application Date: 2022-04-03
-
Publication No.: US20220251170A1Publication Date: 2022-08-11
- Inventor: Eun-ee KOH , Eun Jung LEE , Yoo Soo YANG , In-San KIM
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seoul
- Priority: KR10-2016-018573 20161229
- Main IPC: C07K14/71
- IPC: C07K14/71 ; A61P35/00 ; C12N9/12
Abstract:
The present invention provides a recombinant exosome and uses thereof. More particularly, the present invention provides a recombinant exosome wherein a phagocytosis promoting protein is presented on the surface of the exosome.
Public/Granted literature
- US11952412B2 Exosome-based anticancer agent Public/Granted day:2024-04-09
Information query
